Commencing a new series called Pioneers in Health Care, is an interview with Professor Jeremy Chapman AC who for over 30 years, has been involved in nephrectomy, or kidney transplantation.
Honoured “for eminent service to medicine, particularly in the areas of clinical and biomedical research, to the development of ethical policy and practices for organ donation, acquisition and transplantation, and to renal medicine organisations and publications, Jeremy Chapman AC has played significant roles in development of kidney, pancreas and unrelated Bone Marrow Transplantation in Australia.
He has been responsible for global development of ethical transplantation through The Transplantation Society, the World Marrow Donor Association and through advisory roles to the World Health Organisation. He is identified as one of the most influential global leaders in the field of clinical transplantation.
Credit: Australian Academy of Health and Medical Sciences
In September 2022, Western Sydney’s Professor Jeremy Chapman was bestowed the prestigious 2022 Medawar Prize on-stage in Buenos Aires, Argentina.
The Medawar Prize, awarded biennially since 1990 and named after Society co-founder Sir Peter Medawar, is globally recognised as the most prestigious award for excellence in Transplantation Science and Jeremy is “surprised and honoured” saying “not many people get this award so it’s a true delight”.
The award recognises outstanding investigators whose contributions have profoundly influenced organ transplantation.
Professor Chapman has dedicated much of his career to clinical care and research at Westmead, since commencing as a renal physician at Westmead Hospital in 1987. He has worked as Director of Western Renal Services, Westmead Hospital’s Director of Medicine and Cancer, as well as the Director of the Westmead Hospital Foundation, Chair of the Westmead Research Hub Council and member and deputy chair of the board of WSLHD.
In the early days of transplantation long-term care of transplant patients was mostly undertaken by transplant surgeons but as both the numbers and the complexity of transplantation increased, Professor Chapman was amongst the vanguard of renal physicians that focussed, as a physician, on care of patients after their transplant.
“It’s been an interesting road of discovery over time, but also a major transformation in the outcome for our patients,” Professor Chapman said.
“When I was first involved in 1978, we thought a 60% success rate at one year after a transplant was pretty good, even when choosing the very best patients to transplant, now, we would expect more than 90 or 95% success rates in much, much older and sicker patients.”
“Australia has been a great springboard for global activity, so it’s worked out very well to be working in Australia to impact on transplantation globally.”, according to Professor Chapman.
You Might also like
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
Jamie Stanistreet talks Medical Technology
Jamie Stanistreet
Retired Managing Director Medtronic Australia and New Zealand
talks Medical Technology in Australia and the Asia-Pacific -
Care workforce challenges
In a wide ranging report looking at the carer needs across Australia, PwC Australia published Reimagine Care Workforce Solutions in October 2022.
Australian Health Journal spoke with Kerryn Dillon, Director Ageing and Reablement and Health Workforce at PwC Australia about the community care sectors of aged care, disability care and childcare the report covers.